Suppr超能文献

aged大蒜提取物可降低糖尿病患者的左心室心肌质量:一项前瞻性随机对照双盲研究。 (你提供的原文中“aged”可能有误,正确的可能是“aged garlic extract”即“ aged大蒜提取物”,这里按照正确理解翻译,若原文无误请忽略)

Aged garlic extract reduces left ventricular myocardial mass in patients with diabetes: A prospective randomized controlled double-blind study.

作者信息

Hutchins Elizabeth, Shaikh Kashif, Kinninger April, Cherukuri Lavanya, Birudaraju Divya, Mao Song Shou, Nakanishi Rine, Almeida Shone, Jayawardena Eranthi, Shekar Chandana, Flores Fredinand, Hamal Sajad, Sheikh Salman, Johanis Amit, Cu Benedict, Trad George, Budoff Matthew J

机构信息

Los Angeles Biomedical Institute at Harbor-UCLA Medical Institute, Torrance, CA 90502, USA.

出版信息

Exp Ther Med. 2020 Feb;19(2):1468-1471. doi: 10.3892/etm.2019.8373. Epub 2019 Dec 27.

Abstract

Increased left ventricular myocardial mass (LVM) is a well known prognostic marker of poor cardiac outcomes. Decreases in LVM have been shown to decrease the cardiovascular risk. Aged garlic extract (AGE) has been shown to have an overall favorable effect on cardiac health; however, to the best of our knowledge, no study to date has specifically examined its effects on left ventricular mass. This study investigated whether AGE can affect LVM measured by cardiac computed tomography angiography (CCTA) in patients with diabetes mellitus (DM). This is a double-blind, placebo controlled randomized trial. In total, 65 participants with DM with a mean age of 58 years were prospectively assigned to consume 2,400 mg AGE/day or the placebo orally. Both groups underwent CCTA at baseline and follow-up at 1 year apart. LVM was measured using automated software. The baseline characteristics did not differ between the AGE and placebo groups. There was a trend towards a significant reduction in LVM at follow-up as compared to baseline in the AGE group (119.30±34.77 vs. 121.0±34.70, P=0.059). No change was observed in LVM in the placebo group at 1-year follow-up as compared to baseline (124.6±37.33 vs. 124.6±35.13, P=0.9). On the whole, this study indicated that AGE may decrease or stabilize LVM. Further studies however, with a larger sample size and longer follow-up times are required to evaluate the effects of AGE on hypertension and LVM.

摘要

左心室心肌质量(LVM)增加是心脏不良预后的一个众所周知的预测指标。已证实LVM降低可降低心血管风险。老年大蒜提取物(AGE)已被证明对心脏健康具有总体有益作用;然而,据我们所知,迄今为止尚无研究专门考察其对左心室质量的影响。本研究调查了AGE是否会影响糖尿病(DM)患者通过心脏计算机断层扫描血管造影(CCTA)测量的LVM。这是一项双盲、安慰剂对照的随机试验。总共65名平均年龄为58岁的DM患者被前瞻性地分配为每日口服2400毫克AGE或安慰剂。两组在基线时以及相隔1年的随访时均接受CCTA检查。使用自动化软件测量LVM。AGE组和安慰剂组的基线特征无差异。与基线相比,AGE组随访时LVM有显著降低的趋势(119.30±34.77 vs. 121.0±34.70,P = 0.059)。与基线相比,安慰剂组在1年随访时LVM未观察到变化(124.6±37.33 vs. 124.6±35.13,P = 0.9)。总体而言,本研究表明AGE可能会降低或稳定LVM。然而,需要进一步开展样本量更大、随访时间更长的研究来评估AGE对高血压和LVM的影响。

相似文献

引用本文的文献

3
Aged Garlic Extract Reduces IL-6: A Double-Blind Placebo-Controlled Trial in Females with a Low Risk of Cardiovascular Disease.aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-6: a double-blind placebo-controlled trial in females with a low risk of cardiovascular disease. aged garlic extract reduces il-
Evid Based Complement Alternat Med. 2021 Mar 31;2021:6636875. doi: 10.1155/2021/6636875. eCollection 2021.

本文引用的文献

2
Garlic and Heart Disease.大蒜与心脏病
J Nutr. 2016 Feb;146(2):416S-421S. doi: 10.3945/jn.114.202333. Epub 2016 Jan 13.
4
Aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial.aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. 老年大蒜提取物和辅酶Q10对炎症标志物和冠状动脉粥样硬化进展有良好影响:一项随机临床试验。
J Cardiovasc Dis Res. 2012 Jul;3(3):185-90. doi: 10.4103/0975-3583.98883.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验